Discuss the role of judicial intervention in compelling regulatory accountability, with reference to the Supreme Court's directions to FSSAI on front-of-pack warning labels.

Regulatory failure in India is often not the absence of law but the absence of closure — rules deliberated endlessly and never notified. The Supreme Court's September 2026 directions to the FSSAI on Front-of-Pack Warning Labels (FoPL) illustrate how courts convert open-ended regulatory discretion into time-bound accountability.

Demanding reasons and timelines

• The Bench of Justices J.B. Pardiwala and K. Vinod Chandran asked FSSAI to justify its two-phase rollout — Phase 1 covering foods high in two or more nutrients of concern (added fat, sugar, salt), Phase 2 extending to even one — cautioning that Phase 2 risks being "indefinitely postponed" [1].
• FSSAI was directed to file an affidavit within 10 days, with hearing on 28 September 2026 — a continuing-mandamus technique that keeps administrative files moving [1].
• The Court probed whether the regime should be mandatory immediately, testing the reasonableness of delegated rule-making under the Food Safety and Standards Act, 2006 [2].

Closing the mandate–delivery gap

• FSSAI has deliberated FoPL since 2021–22, evaluating Nutri-Score, Health Star Rating and warning symbols, aided by an IIM Ahmedabad consumer study, yet the red hexagonal label remains un-notified.
• Judicial review here supplies deadline discipline that internal review rarely enforces, while treating a PIL as a vehicle for diffuse consumer interests.

Public health stake

• NCDs account for roughly two-thirds of India's disease burden [4], and the WHO treats FoPL as a cost-effective consumer-alert tool underpinned by nutrient-profiling [3]; the Court's suggestion of nutrition education in schools builds the capability to actually use labels [1].

Limits of the intervention

• Courts lack expertise to fix nutrient thresholds; industry reformulation time and consumer comprehension are legitimate regulatory concerns.
• Judicial calendaring of subordinate legislation must stop at demanding reasons, not drafting standards.

Judicial intervention thus works best as an accountability trigger rather than a substitute regulator. FSSAI should notify a scientifically justified FoPL regime with a firm outer date for Phase 2 and published compliance monitoring — advancing the right to health under Article 21 and SDG-3, and vindicating the Court's insistence that regulatory discretion carries a duty to act.